COVID-19 Molecular Diagnostics Market
1 Introduction to Research & Analysis Reports
1.1 COVID-19 Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 Molecular Diagnostics Overall Market Size
2.1 Global COVID-19 Molecular Diagnostics Market Size: 2022 VS 2028
2.2 Global COVID-19 Molecular Diagnostics Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key COVID-19 Molecular Diagnostics Players in Global Market
3.2 Global Companies COVID-19 Molecular Diagnostics Product & Technology
4 Players Profiles
4.1 Cellex
4.1.1 Cellex Corporate Summary
4.1.2 Cellex Business Overview
4.1.3 Cellex COVID-19 Molecular Diagnostics Product Offerings & Technology
4.1.4 Cellex COVID-19 Molecular Diagnostics R&D, and Plans
4.2 Abbott
4.2.1 Abbott Corporate Summary
4.2.2 Abbott Business Overview
4.2.3 Abbott COVID-19 Molecular Diagnostics Product Offerings & Technology
4.2.4 Abbott COVID-19 Molecular Diagnostics R&D, and Plans
4.3 Roche
4.3.1 Roche Corporate Summary
4.3.2 Roche Business Overview
4.3.3 Roche COVID-19 Molecular Diagnostics Product Offerings & Technology
4.3.4 Roche COVID-19 Molecular Diagnostics R&D, and Plans
4.4 BioMedomics
4.4.1 BioMedomics Corporate Summary
4.4.2 BioMedomics Business Overview
4.4.3 BioMedomics COVID-19 Molecular Diagnostics Product Offerings & Technology
4.4.4 BioMedomics COVID-19 Molecular Diagnostics R&D, and Plans
4.5 BD
4.5.1 BD Corporate Summary
4.5.2 BD Business Overview
4.5.3 BD COVID-19 Molecular Diagnostics Product Offerings & Technology
4.5.4 BD COVID-19 Molecular Diagnostics R&D, and Plans
4.6 Henry Schein
4.6.1 Henry Schein Corporate Summary
4.6.2 Henry Schein Business Overview
4.6.3 Henry Schein COVID-19 Molecular Diagnostics Product Offerings & Technology
4.6.4 Henry Schein COVID-19 Molecular Diagnostics R&D, and Plans
4.7 Safecare Bio-Tech
4.7.1 Safecare Bio-Tech Corporate Summary
4.7.2 Safecare Bio-Tech Business Overview
4.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.7.4 Safecare Bio-Tech COVID-19 Molecular Diagnostics R&D, and Plans
4.8 Thermo Fisher
4.8.1 Thermo Fisher Corporate Summary
4.8.2 Thermo Fisher Business Overview
4.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Product Offerings & Technology
4.8.4 Thermo Fisher COVID-19 Molecular Diagnostics R&D, and Plans
4.9 Bio-rad
4.9.1 Bio-rad Corporate Summary
4.9.2 Bio-rad Business Overview
4.9.3 Bio-rad COVID-19 Molecular Diagnostics Product Offerings & Technology
4.9.4 Bio-rad COVID-19 Molecular Diagnostics R&D, and Plans
4.10 Agilent
4.10.1 Agilent Corporate Summary
4.10.2 Agilent Business Overview
4.10.3 Agilent COVID-19 Molecular Diagnostics Product Offerings & Technology
4.10.4 Agilent COVID-19 Molecular Diagnostics R&D, and Plans
4.11 Ortho Clinical Diagnostics
4.11.1 Ortho Clinical Diagnostics Corporate Summary
4.11.2 Ortho Clinical Diagnostics Business Overview
4.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Offerings & Technology
4.11.4 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics R&D, and Plans
4.12 Zhejiang Orient Gene Biotech
4.12.1 Zhejiang Orient Gene Biotech Corporate Summary
4.12.2 Zhejiang Orient Gene Biotech Business Overview
4.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.12.4 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics R&D, and Plans
4.13 Innovita Biological Technology
4.13.1 Innovita Biological Technology Corporate Summary
4.13.2 Innovita Biological Technology Business Overview
4.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Product Offerings & Technology
4.13.4 Innovita Biological Technology COVID-19 Molecular Diagnostics R&D, and Plans
4.14 Guangzhou Wondfo Biotech
4.14.1 Guangzhou Wondfo Biotech Corporate Summary
4.14.2 Guangzhou Wondfo Biotech Business Overview
4.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.14.4 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics R&D, and Plans
4.15 Guangdong Hecin-Scientific
4.15.1 Guangdong Hecin-Scientific Corporate Summary
4.15.2 Guangdong Hecin-Scientific Business Overview
4.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Offerings & Technology
4.15.4 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics R&D, and Plans
4.16 Dynamiker Biotechnology (Tianjin)
4.16.1 Dynamiker Biotechnology (Tianjin) Corporate Summary
4.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
4.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Offerings & Technology
4.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics R&D, and Plans
4.17 ADVAITE
4.17.1 ADVAITE Corporate Summary
4.17.2 ADVAITE Business Overview
4.17.3 ADVAITE COVID-19 Molecular Diagnostics Product Offerings & Technology
4.17.4 ADVAITE COVID-19 Molecular Diagnostics R&D, and Plans
4.18 Mayo Clinic Laboratories
4.18.1 Mayo Clinic Laboratories Corporate Summary
4.18.2 Mayo Clinic Laboratories Business Overview
4.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Offerings & Technology
4.18.4 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics R&D, and Plans
4.19 Chembio Diagnostics
4.19.1 Chembio Diagnostics Corporate Summary
4.19.2 Chembio Diagnostics Business Overview
4.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Product Offerings & Technology
4.19.4 Chembio Diagnostics COVID-19 Molecular Diagnostics R&D, and Plans
4.20 Mount Sinai Laboratory
4.20.1 Mount Sinai Laboratory Corporate Summary
4.20.2 Mount Sinai Laboratory Business Overview
4.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Offerings & Technology
4.20.4 Mount Sinai Laboratory COVID-19 Molecular Diagnostics R&D, and Plans
4.21 QIAGEN
4.21.1 QIAGEN Corporate Summary
4.21.2 QIAGEN Business Overview
4.21.3 QIAGEN COVID-19 Molecular Diagnostics Product Offerings & Technology
4.21.4 QIAGEN COVID-19 Molecular Diagnostics R&D, and Plans
4.22 Bioer
4.22.1 Bioer Corporate Summary
4.22.2 Bioer Business Overview
4.22.3 Bioer COVID-19 Molecular Diagnostics Product Offerings & Technology
4.22.4 Bioer COVID-19 Molecular Diagnostics R&D, and Plans
4.23 Biosynex
4.23.1 Biosynex Corporate Summary
4.23.2 Biosynex Business Overview
4.23.3 Biosynex COVID-19 Molecular Diagnostics Product Offerings & Technology
4.23.4 Biosynex COVID-19 Molecular Diagnostics R&D, and Plans
4.24 Esco
4.24.1 Esco Corporate Summary
4.24.2 Esco Business Overview
4.24.3 Esco COVID-19 Molecular Diagnostics Product Offerings & Technology
4.24.4 Esco COVID-19 Molecular Diagnostics R&D, and Plans
4.25 Analytik Jena
4.25.1 Analytik Jena Corporate Summary
4.25.2 Analytik Jena Business Overview
4.25.3 Analytik Jena COVID-19 Molecular Diagnostics Product Offerings & Technology
4.25.4 Analytik Jena COVID-19 Molecular Diagnostics R&D, and Plans
4.26 Techne
4.26.1 Techne Corporate Summary
4.26.2 Techne Business Overview
4.26.3 Techne COVID-19 Molecular Diagnostics Product Offerings & Technology
4.26.4 Techne COVID-19 Molecular Diagnostics R&D, and Plans
4.27 Da An Gene
4.27.1 Da An Gene Corporate Summary
4.27.2 Da An Gene Business Overview
4.27.3 Da An Gene COVID-19 Molecular Diagnostics Product Offerings & Technology
4.27.4 Da An Gene COVID-19 Molecular Diagnostics R&D, and Plans
4.28 BGI
4.28.1 BGI Corporate Summary
4.28.2 BGI Business Overview
4.28.3 BGI COVID-19 Molecular Diagnostics Product Offerings & Technology
4.28.4 BGI COVID-19 Molecular Diagnostics R&D, and Plans
4.29 Shanghai ZJ Bio-Tech
4.29.1 Shanghai ZJ Bio-Tech Corporate Summary
4.29.2 Shanghai ZJ Bio-Tech Business Overview
4.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.29.4 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics R&D, and Plans
5 Sights by Region
5.1 By Region - Global COVID-19 Molecular Diagnostics Market Size, 2023 & 2028
5.2 By Region - Global COVID-19 Molecular Diagnostics Revenue, (2023-2028)
5.3 United States
5.3.1 Key Players of COVID-19 Molecular Diagnostics in United States
5.3.2 United States COVID-19 Molecular Diagnostics Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 Molecular Diagnostics in Europe
5.4.2 Europe COVID-19 Molecular Diagnostics Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 Molecular Diagnostics in China
5.5.2 China COVID-19 Molecular Diagnostics Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 by Type - Global COVID-19 Molecular Diagnostics Market Size Markets, 2023 & 2028
6.2 High-throughput Sequencing
6.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
6.4 Immunological Detection
7 Sights by Application
7.1 By Application - Global COVID-19 Molecular Diagnostics Market Size, 2023 & 2028
7.2 Hospitals
7.3 Scientific Research
7.4 Biodiagnostics
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. COVID-19 Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. COVID-19 Molecular Diagnostics Market Drivers in Global Market
Table 3. COVID-19 Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of COVID-19 Molecular Diagnostics in Global Market
Table 5. Global Companies COVID-19 Molecular Diagnostics Product & Technology
Table 6. Cellex Corporate Summary
Table 7. Cellex COVID-19 Molecular Diagnostics Product Offerings
Table 8. Abbott Corporate Summary
Table 9. Abbott COVID-19 Molecular Diagnostics Product Offerings
Table 10. Roche Corporate Summary
Table 11. Roche COVID-19 Molecular Diagnostics Product Offerings
Table 12. BioMedomics Corporate Summary
Table 13. BioMedomics COVID-19 Molecular Diagnostics Product Offerings
Table 14. BD Corporate Summary
Table 15. BD COVID-19 Molecular Diagnostics Product Offerings
Table 16. Henry Schein Corporate Summary
Table 17. Henry Schein COVID-19 Molecular Diagnostics Product Offerings
Table 18. Safecare Bio-Tech Corporate Summary
Table 19. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Offerings
Table 20. Thermo Fisher Corporate Summary
Table 21. Thermo Fisher COVID-19 Molecular Diagnostics Product Offerings
Table 22. Bio-rad Corporate Summary
Table 23. Bio-rad COVID-19 Molecular Diagnostics Product Offerings
Table 24. Agilent Corporate Summary
Table 25. Agilent COVID-19 Molecular Diagnostics Product Offerings
Table 26. Ortho Clinical Diagnostics Corporate Summary
Table 27. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Offerings
Table 28. Zhejiang Orient Gene Biotech Corporate Summary
Table 29. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Offerings
Table 30. Innovita Biological Technology Corporate Summary
Table 31. Innovita Biological Technology COVID-19 Molecular Diagnostics Product Offerings
Table 32. Guangzhou Wondfo Biotech Corporate Summary
Table 33. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Offerings
Table 34. Guangdong Hecin-Scientific Corporate Summary
Table 35. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Offerings
Table 36. Dynamiker Biotechnology (Tianjin) Corporate Summary
Table 37. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Offerings
Table 38. ADVAITE Corporate Summary
Table 39. ADVAITE COVID-19 Molecular Diagnostics Product Offerings
Table 40. Mayo Clinic Laboratories Corporate Summary
Table 41. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Offerings
Table 42. Chembio Diagnostics Corporate Summary
Table 43. Chembio Diagnostics COVID-19 Molecular Diagnostics Product Offerings
Table 44. Mount Sinai Laboratory Corporate Summary
Table 45. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Offerings
Table 46. QIAGEN Corporate Summary
Table 47. QIAGEN COVID-19 Molecular Diagnostics Product Offerings
Table 48. Bioer Corporate Summary
Table 49. Bioer COVID-19 Molecular Diagnostics Product Offerings
Table 50. Biosynex Corporate Summary
Table 51. Biosynex COVID-19 Molecular Diagnostics Product Offerings
Table 52. Esco Corporate Summary
Table 53. Esco COVID-19 Molecular Diagnostics Product Offerings
Table 54. Analytik Jena Corporate Summary
Table 55. Analytik Jena COVID-19 Molecular Diagnostics Product Offerings
Table 56. Techne Corporate Summary
Table 57. Techne COVID-19 Molecular Diagnostics Product Offerings
Table 58. Da An Gene Corporate Summary
Table 59. Da An Gene COVID-19 Molecular Diagnostics Product Offerings
Table 60. BGI Corporate Summary
Table 61. BGI COVID-19 Molecular Diagnostics Product Offerings
Table 62. Shanghai ZJ Bio-Tech Corporate Summary
Table 63. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Offerings
Table 64. By Region? Global COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2023 & 2028
Table 65. By Region - Global COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 66. By Type ? Global COVID-19 Molecular Diagnostics Market Size, (US$, Mn), 2023 & 2028
Table 67. By Application? Global COVID-19 Molecular Diagnostics Market Size, (US$, Mn), 2023 & 2028
List of Figures
Figure 1. COVID-19 Molecular Diagnostics Segment by Type in 2021
Figure 2. COVID-19 Molecular Diagnostics Segment by Application in 2021
Figure 3. Global COVID-19 Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 Molecular Diagnostics Market Size: 2022 VS 2028 (US$, Mn)
Figure 6. Global COVID-19 Molecular Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2023-2028
Figure 8. By Type - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2023-2028
Figure 9. By Application - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2023-2028
Industry Market Size
